HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masunori Matsuzaki Selected Research

2- butyl- 3- ((2'- (1H- tetrazol- 5- yl)biphenyl- 4- yl)methyl)- 3H- imidazo(4,5- b)pyridine

9/2004Effects of angiotensin II type 1 receptor antagonist on smooth muscle cell phenotype in intramyocardial arteries from spontaneously hypertensive rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masunori Matsuzaki Research Topics

Disease

60Heart Failure
12/2017 - 01/2002
28Coronary Artery Disease (Coronary Atherosclerosis)
10/2022 - 04/2003
22Hypertension (High Blood Pressure)
02/2021 - 01/2002
17Hypercholesterolemia
01/2012 - 05/2002
15Acute Coronary Syndrome
08/2016 - 01/2002
14Stroke (Strokes)
01/2020 - 11/2004
10Coronary Disease (Coronary Heart Disease)
02/2021 - 01/2002
10Myocardial Infarction
01/2018 - 01/2003
10Cardiac Arrhythmias (Arrythmia)
12/2012 - 07/2002
8Atrial Fibrillation
01/2014 - 01/2002
8Polymorphic catecholergic ventricular tachycardia
08/2011 - 09/2005
8Fibrosis (Cirrhosis)
08/2010 - 05/2002
7Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 03/2003
7Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2010 - 01/2002
6Diabetes Mellitus
11/2013 - 01/2002
6Atherosclerosis
01/2013 - 05/2002
6Ventricular Remodeling
01/2012 - 03/2002
6Abdominal Aortic Aneurysm
10/2011 - 12/2005
6Ventricular Tachycardia
08/2011 - 06/2005
6Infarction (Infarctions)
11/2010 - 04/2002
6Atherosclerotic Plaque (Atheroma)
09/2010 - 07/2002
6Cardiomyopathies (Cardiomyopathy)
01/2010 - 07/2004
5Vascular Remodeling
10/2015 - 09/2004
5Myocarditis (Carditis)
03/2013 - 01/2002
5Tachycardia (Tachyarrhythmias)
01/2012 - 07/2002
5Body Weight (Weight, Body)
12/2011 - 01/2003
4Inflammation (Inflammations)
10/2015 - 05/2003
3Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
02/2021 - 07/2002
3Dyslipidemias (Dyslipidemia)
02/2021 - 01/2011
3Systolic Heart Failure
01/2014 - 09/2005
3Chronic Renal Insufficiency
11/2013 - 03/2008
3Heart Diseases (Heart Disease)
07/2010 - 12/2006
3Obesity
03/2010 - 09/2007
3Hypertrophy
12/2006 - 02/2003
3Hypoxia (Hypoxemia)
08/2006 - 08/2002
3Hypotension (Low Blood Pressure)
01/2006 - 01/2003
3Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2005 - 02/2003
2Stable Angina
10/2021 - 02/2008
2Xanthomatosis (Xanthoma)
02/2021 - 06/2016
2Pathologic Constriction (Stenosis)
06/2017 - 10/2005
2Sarcoidosis (Schaumann Disease)
06/2016 - 01/2015
2Thrombosis (Thrombus)
04/2016 - 03/2012

Drug/Important Bio-Agent (IBA)

31LipidsIBA
10/2022 - 01/2002
24Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2022 - 12/2006
18Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
12/2012 - 03/2002
13pitavastatin (itavastatin)FDA Link
10/2022 - 11/2006
11Angiotensin Receptor AntagonistsIBA
01/2018 - 10/2002
9LDL CholesterolIBA
10/2022 - 01/2002
9Simvastatin (Zocor)FDA LinkGeneric
03/2010 - 12/2002
9CholesterolIBA
08/2008 - 01/2002
8benidipineIBA
01/2020 - 08/2011
8Atorvastatin (Lipitor)FDA Link
01/2013 - 12/2006
8Eicosapentaenoic AcidIBA
01/2012 - 07/2008
8Proteins (Proteins, Gene)FDA Link
01/2012 - 08/2002
7oxidized low density lipoproteinIBA
02/2021 - 07/2002
7Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA
01/2018 - 04/2005
7Carvedilol (Coreg)FDA LinkGeneric
03/2014 - 02/2004
6HDL CholesterolIBA
01/2022 - 09/2005
6CalciumIBA
11/2013 - 01/2003
6Pharmaceutical PreparationsIBA
05/2009 - 05/2002
5AntioxidantsIBA
02/2021 - 05/2002
5ThiazidesIBA
01/2020 - 04/2012
5Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2020 - 08/2011
5Biomarkers (Surrogate Marker)IBA
06/2016 - 09/2007
5Angiotensin IIIBA
10/2015 - 01/2003
5EnzymesIBA
10/2015 - 05/2003
5Triglycerides (Triacylglycerol)IBA
01/2015 - 01/2002
5DiureticsIBA
01/2014 - 12/2011
5CytokinesIBA
08/2008 - 01/2003
5Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
09/2005 - 10/2002
4Probucol (Lorelco)FDA Link
02/2021 - 05/2002
48-Hydroxy-2'-DeoxyguanosineIBA
06/2016 - 01/2011
4Reactive Oxygen Species (Oxygen Radicals)IBA
10/2015 - 01/2005
4NADPH Oxidases (NAD(P)H oxidase)IBA
10/2015 - 05/2002
4Rosuvastatin Calcium (Crestor)FDA Link
12/2013 - 02/2007
4TolvaptanFDA Link
12/2011 - 12/2011
4JNK Mitogen-Activated Protein KinasesIBA
10/2007 - 12/2005
4Nitric Oxide Synthase (NO Synthase)IBA
01/2005 - 05/2002
3LDL Lipoproteins (beta Lipoproteins)IBA
02/2021 - 07/2002
31,4-dihydropyridine (dihydropyridine)IBA
01/2018 - 12/2013
3Sirolimus (Rapamycin)FDA Link
04/2016 - 02/2008
3C-Reactive ProteinIBA
01/2015 - 09/2007
3Protein Phosphatase 1IBA
01/2012 - 06/2006
3Amino AcidsFDA Link
08/2011 - 11/2004
3Dantrolene (Dantrium)FDA LinkGeneric
08/2011 - 05/2009
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2008 - 01/2003
3Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
06/2006 - 03/2002
3tacrolimus binding protein 1BIBA
03/2003 - 03/2002
2Mineralocorticoid Receptor AntagonistsIBA
12/2017 - 03/2011
2Toll-Like Receptor 4IBA
10/2015 - 08/2015
2Norepinephrine (Noradrenaline)FDA LinkGeneric
10/2015 - 10/2010
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
08/2015 - 02/2010
2Prednisolone (Predate)FDA LinkGeneric
01/2015 - 05/2003

Therapy/Procedure

53Therapeutics
10/2022 - 04/2002
6Stents
06/2017 - 05/2002
5Secondary Prevention
02/2021 - 12/2002
5Percutaneous Coronary Intervention
11/2010 - 11/2004
3Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2011 - 03/2003
3Ligation
07/2003 - 04/2002
3Heart Transplantation (Grafting, Heart)
07/2003 - 01/2002